Sign in

CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company

TALPHERA, INC.

Sign in to watch
Ticker
TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
412193603
Phone
650-216-3500
Business address
1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
Former names
ACELRX PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-10-23 Broadfoot Jill Marie Director Grant or award · Stock Option (Right to Buy) +25,600 25,600
2025-10-23 ADAMS ADRIAN Director Grant or award +4,267 17,609
2025-10-23 ADAMS ADRIAN Director Grant or award · Stock Option (Right to Buy) +25,600 25,600
2025-10-23 WAN MARK A Director Grant or award +4,267 8,859
2025-10-23 WAN MARK A Director Grant or award · Stock Option (Right to Buy) +25,600 25,600
2025-10-23 HOFFMAN STEPHEN J Director Grant or award +4,267 8,859
2025-10-23 HOFFMAN STEPHEN J Director Grant or award · Stock Option (Right to Buy) +25,600 25,600
2025-10-15 Todisco Joseph Director Grant or award +6,397 6,397
2025-10-15 Todisco Joseph Director Grant or award · Director Stock Option (right to buy) +38,381 38,381
2025-05-20 Aslam Shakil Chief Medical Officer Shares withheld for taxes −4,517 $0.52 $2K 48,178
2025-04-02 Aslam Shakil Chief Medical Officer Grant or award +15,000 52,695
2025-04-02 Aslam Shakil Chief Medical Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2025-04-02 Dasu Badri N Chief Engineering Officer Grant or award +15,000 42,011
2025-04-02 Dasu Badri N Chief Engineering Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2025-04-02 ASADORIAN RAFFI Chief Financial Officer Grant or award +15,000 47,214
2025-04-02 ASADORIAN RAFFI Chief Financial Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2025-04-02 Angotti Vincent J. CHIEF EXECUTIVE OFFICER Purchase +213,310 $0.59 $125K 403,769
2025-04-02 Angotti Vincent J. CHIEF EXECUTIVE OFFICER Grant or award +61,000 474,769
2025-04-02 Angotti Vincent J. CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +365,000 365,000
2025-03-31 Nantahala Capital Management, LLC 10% owner Grant or award · Pre-Funded Warrants +4,266,211 $0.59 $2.5M 11,510,601

Page 3 of 9 · 179 trades